FDA Regulations and Recommendations for Failure Investigations

Click to download
Reviews
Shared by: FDADocs
Stats
views:
97
rating:
not rated
reviews:
0
posted:
5/5/2008
language:
pages:
0
FDA Regulations and Recommendations for Failure Investigations Hoi-may Wong, BS, MT(ACSP)SBB Blood and Plasma Branch Division of Blood Applications, FDA, CBER, OBRR FDA Workshop Licensure of Apheresis Blood Products August 15, 2007 Regulations • 21 CFR 211.192, Product Record Review All drug product production and control records…shall be reviewed … before a batch is released or distributed. Any unexplained discrepancy or failure … shall be thoroughly investigated… The investigation should extend to other batches … that may have been associated with the specific failure or discrepancy. A written record of the investigation … shall include the conclusions and followup. Regulations (continued) • 21 CFR 606.100(c), Standard Operating Procedures All records pertinent to the lot …shall be reviewed before the release or distribution … of final product. The review … may be performed at appropriate periods during or after collecting, processing, or compatibility testing and storing. A thorough investigation, including the conclusions and followup, of any unexplained discrepancy or failure…shall be made and recorded. Examples of manufacturing process deviations that warrant investigation • • • • • Equipment validation Donor suitability/eligibility Device QC Components not meeting product specifications What is a Thorough Investigation? An investigation of the critical steps or areas where an unexplained discrepancy or failure resulted. • • • • • What's the problem? When / where did it happen? Why did it happen? How to prevent it from recurring? Documentations Examples of critical steps or areas • • • • • • • • Donor Operator Supplies and reagents Device Components Environment SOPs Samples Examples of critical steps or areas (continued) • Donors - characteristics - specifications • Operator - performance - training/competency Examples of critical steps or areas (continued) • Supplies and reagent - lots • Device - performance - operation - controls - device validation / calibration - maintenance Examples of critical steps or areas (continued) • Components - specification - collection • Environment - storage - shipping Examples of critical steps or areas (continued) • SOPs - adherence to - adequacy of • Samples - type - collection - storage / shipping Closing Notes • Any unexplained discrepancy may have more than a single cause. • An apparent deviation may have multiple impacts on the final products. • Shifts and trends enable the detection of unexplained discrepancies or failures.

Related docs
fraud investigations
Views: 222  |  Downloads: 15
Summary Recommendations to FDA
Views: 10  |  Downloads: 0
CDER Pre Approval Inspections Investigations
Views: 108  |  Downloads: 5
FDA Prehistory
Views: 5  |  Downloads: 0
FDA Tarceva Clinical Review
Views: 174  |  Downloads: 3
FDA Approvable Letter Andreason
Views: 46  |  Downloads: 0
FDA Institutional Review Board Inspections
Views: 116  |  Downloads: 2
FDA Complaint for Permanent Injunction
Views: 68  |  Downloads: 1
Other docs by FDADocs
Stephen Colbert
Views: 254  |  Downloads: 0
Notice of Dishonored Check
Views: 204  |  Downloads: 0
ALLEGATION OF JURISDICTION
Views: 193  |  Downloads: 0
r492
Views: 282  |  Downloads: 6
Expedia Inc Ammendments and Bylaws
Views: 221  |  Downloads: 0
2007 Inst W-3 (PR) (PDF) Instructions
Views: 331  |  Downloads: 4
Checklist for Employee Handbooks
Views: 359  |  Downloads: 34
adopt215
Views: 115  |  Downloads: 0
Service providers business plan
Views: 781  |  Downloads: 56
Shareholders Resolution Appointing Directors
Views: 253  |  Downloads: 5